Erratum: BMP pathway regulation of and by macrophages (PLoS ONE (2014) 9, 4 (e94119) DOI:10.1371/journal.pone.0094119);BMP pathway regulation of and by macrophages

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Talati, Megha ^a   West, James ^a   Zaynagetdinov, Rinat ^a   Hong, Charles C ^a,b   Han, Wei ^a   Blackwell, Tom ^a   Robinson, Linda ^a   Blackwell, Timothy S ^a   Lane, Kirk ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CD11B ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; BMPR2 PROTEIN, MOUSE; SMAD PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOKINE RELEASE; DOWN REGULATION; GENOTYPE; LIGAND BINDING; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PNEUMONIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY HYPERTENSION; SMOOTH MUSCLE FIBER; SYSTOLIC BLOOD PRESSURE; UPREGULATION; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL CULTURE; COCULTURE; GENETICS; MACROPHAGE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CELLS, CULTURED; COCULTURE TECHNIQUES; HYPERTENSION, PULMONARY; MACROPHAGES; MICE; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; SIGNAL TRANSDUCTION; SMAD PROTEINS;

EID: 84899455069     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101543     Document Type: Erratum

References (29)

1. Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA 3rd, et al. (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet 26: 81-84.
2. Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, et al. (2001) BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 68: 92-102.
3. Aldred MA, Vijayakrishnan J, James V, Soubrier F, Gomez-Sanchez MA, et al. (2006) BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension. Hum Mutat 27: 212-213.
4. Menon S, Fessel J, West J (2011) Microarray studies in pulmonary arterial hypertension. Int J Clin Pract Suppl: 19-28.
5. Austin ED, Menon S, Hemnes AR, Robinson LR, Talati M, et al. (2011) Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression. Pulm Circ 1: 389-398.
6. Beppu H, Kawabata M, Hamamoto T, Chytil A, Minowa O, et al. (2000) BMP type II receptor is required for gastrulation and early development of mouse embryos. Dev Biol 221: 249-258.
7. Song Y, Jones JE, Beppu H, Keaney JF, Jr., Loscalzo J, et al. (2005) Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice. Circulation 112: 553-562.
8. Johnson JA, Hemnes AR, Perrien DS, Schuster M, Robinson LJ, et al. (2011) Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol.
9. Tada Y, Majka S, Carr M, Harral J, Crona D, et al. (2007) Molecular effects of loss of BMPR2 signaling in smooth muscle in a transgenic mouse model of PAH. Am J Physiol Lung Cell Mol Physiol 292: L1556-1563.
10. West J, Fagan K, Steudel W, Fouty B, Lane K, et al. (2004) Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle. Circ Res 94: 1109-1114.
11. Majka S, Hagen M, Blackwell T, Harral J, Johnson JA, et al. (2011) Physiologic and Molecular Consequences of Endothelial Bmpr2 Mutation. Respir Res 12: 84.
12. Sadikot RT, Jansen ED, Blackwell TR, Zoia O, Yull F, et al. (2001) High-dose dexamethasone accentuates nuclear factor-kappa b activation in endotoxin-treated mice. Am J Respir Crit Care Med 164: 873-878.
13. Sadikot RT, Han W, Everhart MB, Zoia O, Peebles RS, et al. (2003) Selective I kappa B kinase expression in airway epithelium generates neutrophilic lung inflammation. J Immunol 170: 1091-1098.
14. Yull FE, Han W, Jansen ED, Everhart MB, Sadikot RT, et al. (2003) Bioluminescent detection of endotoxin effects on HIV-1 LTR-driven transcription in vivo. J Histochem Cytochem 51: 741-749.
15. Korchynskyi O, ten Dijke P (2002) Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 277: 4883-4891.
16. Cuny GD, Yu PB, Laha JK, Xing X, Liu JF, et al. (2008) Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. Bioorg Med Chem Lett 18: 4388-4392.
17. Lane K, Talati M, Austin E, Hemnes A, Johnson J, et al. (2011) Oxidative injury is a common consequence of BMPR2 mutations. Pulmonary Circulation 1: 72-83.
18. Chamoto K, Gibney BC, Ackermann M, Lee GS, Lin M, et al. (2011) Alveolar macrophage dynamics in murine lung regeneration. J Cell Physiol.
19. Stacher E, Graham BB, Hunt JM, Gandjeva A, Groshong SD, et al. (2012) Modern age pathology of pulmonary arterial hypertension. Am J Respir Crit Care Med 186: 261-272.
20. Majka SM, Skokan M, Wheeler L, Harral J, Gladson S, et al. (2008) Evidence for cell fusion is absent in vascular lesions associated with pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 295: L1028-1039.
21. Price LC, Caramori G, Perros F, Meng C, Gambaryan N, et al. (2013) Nuclear factor kappa-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension. PLoS One 8: e75415.
22. Hagen M, Fagan K, Steudel W, Carr M, Lane K, et al. (2007) Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle. Am J Physiol Lung Cell Mol Physiol 292: L1473-1479.
23. Burton VJ, Ciuclan LI, Holmes AM, Rodman DM, Walker C, et al. (2010) Bone morphogenetic protein receptor-II regulates pulmonary artery endothelial cell barrier function. Blood.
24. Davies RJ, Holmes AM, Deighton J, Long L, Yang X, et al. (2012) BMP type II receptor deficiency confers resistance to growth inhibition by TGF-beta1 in pulmonary artery smooth muscle cells: role of pro-inflammatory cytokines. Am J Physiol Lung Cell Mol Physiol.
25. Konstantinidis G, Moustakas A, Stournaras C (2011) Regulation of myosin light chain function by BMP signaling controls actin cytoskeleton remodeling. Cell Physiol Biochem 28: 1031-1044.
26. Choi KC, Lee YS, Lim S, Choi HK, Lee CH, et al. (2006) Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1. Nat Immunol 7: 1057-1065.
27. Dorfmuller P, Perros F, Balabanian K, Humbert M (2003) Inflammation in pulmonary arterial hypertension. Eur Respir J 22: 358-363.
28. Hassoun PM, Mouthon L, Barbera JA, Eddahibi S, Flores SC, et al. (2009) Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 54: S10-19.
29. Tamosiuniene R, Tian W, Dhillon G, Wang L, Sung YK, et al. (2011) Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension. Circ Res 109: 867-879.